Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme

This publication has 230 references indexed in Scilit:

• Cell cycle effects of the novel topoisomerase I inhibitor NU/ICRF 505 in a panel of chinese hamster ovary cell lines
  European Journal Of Cancer, 1997
• CPT-11 (Irinotecan) in the treatment of colorectal cancer
  European Journal Of Cancer, 1995
• Structure-mutagenicity relationships in series of 11H-indolo[3,2-c]quinoline-1,4-diones, tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones and 11H-pyrido[3′,4′:4,5]pyrrolo[3,2-c]quinoline-1,4-diones with leukemia cytotoxic properties. Relations with topoisomerase I inhibiting properties
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
• A Casein Kinase Type II (CKII)-like Nuclear Protein Kinase Associates with, Phosphorylates, and Activates Topoisomerase I
  Biochemical Medicine and Metabolic Biology, 1993
• DNA Tridimensional Context Affects the Reactivity of Eukaryotic DNA Topoisomerase I
  Journal of Molecular Biology, 1993
• Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line
  Biochemical and Biophysical Research Communications, 1992
• Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability
  Experimental Cell Research, 1989
• A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings
  Cell, 1989
• Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II
  Cell, 1988
• Phosphorylation of purified Novikoff hepatoma topoisomerase I
  Biochemical and Biophysical Research Communications, 1983